Taiwan · Delayed Price · Currency is TWD Senhwa Biosciences Statistics
Total Valuation
TPEX:6492 has a market cap or net worth of TWD 2.65 billion. The enterprise value is 1.29 billion.
| Market Cap | 2.65B |
| Enterprise Value | 1.29B |
Important Dates
The next estimated earnings date is Tuesday, November 17, 2026.
| Earnings Date | Nov 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6492 has 89.39 million shares outstanding. The number of shares has increased by 3.23% in one year.
| Current Share Class | 89.39M |
| Shares Outstanding | 89.39M |
| Shares Change (YoY) | +3.23% |
| Shares Change (QoQ) | +13.65% |
| Owned by Insiders (%) | 6.15% |
| Owned by Institutions (%) | 0.00% |
| Float | 67.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2,765.38 |
| PB Ratio | 1.92 |
| P/TBV Ratio | 1.92 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.43, with a Debt / Equity ratio of 0.01.
| Current Ratio | 22.43 |
| Quick Ratio | 21.80 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -452.35 |
Financial Efficiency
Return on equity (ROE) is -28.40% and return on invested capital (ROIC) is -17.91%.
| Return on Equity (ROE) | -28.40% |
| Return on Assets (ROA) | -17.39% |
| Return on Invested Capital (ROIC) | -17.91% |
| Return on Capital Employed (ROCE) | -23.33% |
| Weighted Average Cost of Capital (WACC) | 8.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TPEX:6492 has paid 1.34 million in taxes.
| Income Tax | 1.34M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.45% in the last 52 weeks. The beta is 0.71, so TPEX:6492's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -29.45% |
| 50-Day Moving Average | 32.90 |
| 200-Day Moving Average | 43.59 |
| Relative Strength Index (RSI) | 32.24 |
| Average Volume (20 Days) | 165,644 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6492 had revenue of TWD 960,000 and -315.41 million in losses. Loss per share was -3.43.
| Revenue | 960,000 |
| Gross Profit | 445,000 |
| Operating Income | -323.88M |
| Pretax Income | -314.07M |
| Net Income | -315.41M |
| EBITDA | -322.31M |
| EBIT | -323.88M |
| Loss Per Share | -3.43 |
Balance Sheet
The company has 1.38 billion in cash and 15.49 million in debt, with a net cash position of 1.36 billion or 15.25 per share.
| Cash & Cash Equivalents | 1.38B |
| Total Debt | 15.49M |
| Net Cash | 1.36B |
| Net Cash Per Share | 15.25 |
| Equity (Book Value) | 1.38B |
| Book Value Per Share | 13.64 |
| Working Capital | 1.36B |
Cash Flow
In the last 12 months, operating cash flow was -262.59 million and capital expenditures -964,000, giving a free cash flow of -263.55 million.
| Operating Cash Flow | -262.59M |
| Capital Expenditures | -964,000 |
| Depreciation & Amortization | 1.57M |
| Net Borrowing | -9.65M |
| Free Cash Flow | -263.55M |
| FCF Per Share | -2.95 |
Margins
| Gross Margin | 46.35% |
| Operating Margin | -33,737.71% |
| Pretax Margin | -32,715.94% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6492 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.23% |
| Shareholder Yield | -3.23% |
| Earnings Yield | -11.54% |
| FCF Yield | -9.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |